LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LSTA LISATA THERAPEUTICS INC

交易中 03-30 11:19:38 EDT

5.01

-0.01

-0.20%

最高5.04	最低5.01	成交量4.58万
今开5.04	昨收5.02	日振幅0.60%
总市值4,525万	流通市值3,645万	总股本903.23万
成交额23.01万	换手率0.63%	流通股本727.58万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LSTA","market":"US","secType":"STK","nameCN":"LISATA THERAPEUTICS INC","latestPrice":5.01,"timestamp":1774883746432,"preClose":5.02,"halted":0,"volume":45760,"delay":0,"changeRate":-0.001992031872509918,"floatShares":7275800,"shares":9032291,"eps":-1.91,"marketStatus":"交易中","change":-0.01,"latestTime":"03-30 11:19:38 EDT","open":5.04,"high":5.04,"low":5.01,"amount":230143.069728,"amplitude":0.005976,"askPrice":5.02,"askSize":2843,"bidPrice":5.01,"bidSize":3882,"shortable":3,"etf":0,"ttmEps":-1.91,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774900800000},"marketStatusCode":2,"adr":0,"listingDate":1186632000000,"exchange":"NASDAQ","adjPreClose":5.02,"preHourTrading":{"tag":"盘前","latestPrice":5.0613,"preClose":5.02,"latestTime":"08:03 EDT","volume":1013,"amount":5126.299669,"timestamp":1774872231188,"change":0.0413,"changeRate":0.008227,"amplitude":0.012211},"postHourTrading":{"tag":"盘后","latestPrice":5.02,"preClose":5.02,"latestTime":"17:28 EDT","volume":57,"amount":285.6,"timestamp":1774646921057,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":6.438913},"requestUrl":"/m/hq/s/LSTA","defaultTab":"news","newsList":[{"id":"1155329362","title":"LISATA THERAPEUTICS INC交易完成后将从纳斯达克退市并终止报告公司身份","url":"https://stock-news.laohu8.com/highlight/detail?id=1155329362","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155329362?lang=zh_cn&edition=full","pubTime":"2026-03-07 07:17","pubTimestamp":1772839030,"startTime":"0","endTime":"0","summary":"LISATA THERAPEUTICS INC宣布，在交易正式完成后，该公司将启动从纳斯达克证券交易所的退市程序，并同时终止其作为证券报告公司的注册义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"gpt_icon":0},{"id":"1109236871","title":"Lisata Therapeutics与齐鲁制药就Certepetide许可协议达成共同终止","url":"https://stock-news.laohu8.com/highlight/detail?id=1109236871","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109236871?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518902,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics（股票代码：LSTA）近日宣布，已与齐鲁制药就Certepetide的许可协议达成共同终止协议。双方一致同意终止该协议，结束此前在Certepetide项目上的合作关系。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"gpt_icon":0},{"id":"1157804762","title":"行动结果：授予齐鲁的所有许可及其他权利全部回归Lisata Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1157804762","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157804762?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518873,"startTime":"0","endTime":"0","summary":"根据最新行动结果，此前授予齐鲁的所有许可协议及相关权利现已全部归还至Lisata Therapeutics Inc。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LSTA"],"gpt_icon":0},{"id":"1198536333","title":"Lisata Therapeutics股价盘前飙升84.26%至3.98美元，获Kuva Labs以每股4美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1198536333","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198536333?lang=zh_cn&edition=full","pubTime":"2026-01-21 21:55","pubTimestamp":1769003712,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics股价在盘前交易中大幅上涨84.26%，报收于3.98美元。此前，该公司宣布将被Kuva Labs以每股4美元的价格全面收购。\n这一收购报价较Lisata Therapeutics近期股价存在显著溢价，反映出市场对该交易的高度认可。受此消息提振，投资者积极买入，推动股价急速攀升。\n生物制药领域再现并购案例，此次交易有望为Lisata Therapeutics的发展注入新动力。市场普遍关注后续收购流程的推进情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"gpt_icon":0},{"id":"1178246193","title":"LISATA THERAPEUTICS INC与Kuva Labs签订条款书，将以每股4.00美元的全现金要约收购方式被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1178246193","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178246193?lang=zh_cn&edition=full","pubTime":"2026-01-21 20:01","pubTimestamp":1768996888,"startTime":"0","endTime":"0","summary":"LISATA THERAPEUTICS INC已与Kuva Labs达成一项条款书，根据该协议，Kuva Labs将以每股4.00美元的价格，通过全现金要约收购的方式对LISATA THERAPEUTICS INC进行收购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LSTA"],"gpt_icon":0},{"id":"1175681521","title":"Lisata Therapeutics 第三季度每股收益为 -0.49 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175681521","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175681521?lang=zh_cn&edition=full","pubTime":"2025-11-07 05:28","pubTimestamp":1762464499,"startTime":"0","endTime":"0","summary":"11月6日 - Lisata Therapeutics 第三季度运营费用为 441.4 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"gpt_icon":0},{"id":"1134406275","title":"Lisata Therapeutics 强调 Certepetide 作为抗体药物偶联物组合的积极前临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1134406275","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134406275?lang=zh_cn&edition=full","pubTime":"2025-11-05 05:01","pubTimestamp":1762290074,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics 强调 Certepetide 作为抗体药物偶联物组合的积极前临床数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT","BK4139","LSTA","BK4588","BK4585","BK4007","BK4530"],"gpt_icon":0},{"id":"1104965787","title":"Lisata Therapeutics公布Cendifox试验胰腺癌患者群体的积极初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1104965787","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104965787?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:02","pubTimestamp":1759147355,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics发布了其Cendifox临床试验中胰腺癌患者队列的令人振奋的初步研究成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LSTA"],"gpt_icon":0},{"id":"2517466947","title":"Lisata Therapeutics, Inc.2024财年实现净利润-19.99百万美元，同比增加4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517466947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517466947?lang=zh_cn&edition=full","pubTime":"2025-03-08 02:00","pubTimestamp":1741370441,"startTime":"0","endTime":"0","summary":"3月8日，Lisata Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-19.99百万美元，同比增加4.08%；其中营业收入为1000000.00美元，每股基本收益为-2.40美元。从资产负债表来看，Lisata Therapeutics, Inc.总负债5.69百万美元，其中短期债务137000.00美元，资产负债比为6.16，流动比率为6.17。机构评级：截至2025年3月8日，当前有3家机构对Lisata Therapeutics, Inc.目标价做出预测，其中目标均价为17.00美元，其中最低目标价为15.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308020042abed9a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308020042abed9a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LSTA"],"gpt_icon":0},{"id":"2517288449","title":"Lisata Therapeutics, Inc.盘中异动 股价大涨8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517288449?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:13","pubTimestamp":1741198384,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时13分，Lisata Therapeutics, Inc.股票出现波动，股价急速拉升8.84%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021304963b0d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021304963b0d55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2514356932","title":"Lisata Therapeutics(LSTA.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.55美元，前值为-0.66美元，预期值为-0.76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514356932","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514356932?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:00","pubTimestamp":1740693657,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics(LSTA.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.55美元，前值为-0.66美元，预期值为-0.76美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28060048442427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LSTA","LENZ"],"gpt_icon":0},{"id":"1137320550","title":"Lisata Therapeutics 第四季度 GAAP 每股收益 $(0.55) 超出 $(0.79) 的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1137320550","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137320550?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:00","pubTimestamp":1740693652,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics  报告季度每股亏损 $，超出分析师一致预期的 $，超出预期 30.38%。与去年同期每股亏损 $ 相比，这是一种 16.67% 的改善。以上内容来自Benzinga Earnings专栏，原文如下：Lisata $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 30.38 percent. This is a 16.67 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LSTA"],"gpt_icon":0},{"id":"2514385668","title":"Lisata Therapeutics, Inc.盘中异动 早盘急速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385668?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:44","pubTimestamp":1740667494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时44分，Lisata Therapeutics, Inc.股票出现异动，股价急速拉升5.44%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224454a2567d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224454a2567d97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2514075859","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌7.28%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514075859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514075859?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Lisata Therapeutics, Inc.股票出现波动，股价急速跳水7.28%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4662.94%、160.61%、143.94%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304119893b141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304119893b141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","LENZ","BK4139"],"gpt_icon":0},{"id":"2514323015","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514323015?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:20","pubTimestamp":1740496831,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时20分，Lisata Therapeutics, Inc.股票出现异动，股价急速跳水5.23%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232032989257c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232032989257c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2513773368","title":"Lisata Therapeutics, Inc.盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513773368?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:16","pubTimestamp":1740410171,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时16分，Lisata Therapeutics, Inc.股票出现波动，股价快速跳水5.05%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231612962ea39c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231612962ea39c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","LENZ","BK4139"],"gpt_icon":0},{"id":"2513213519","title":"Lisata Therapeutics, Inc.盘中异动 急速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213519?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:32","pubTimestamp":1740159140,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时32分，Lisata Therapeutics, Inc.股票出现异动，股价大幅下跌5.15%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013220962ba348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013220962ba348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LSTA"],"gpt_icon":0},{"id":"2512165183","title":"Lisata Therapeutics, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165183?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:39","pubTimestamp":1739889541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时39分，Lisata Therapeutics, Inc.股票出现异动，股价快速上涨5.78%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223901abd3b0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223901abd3b0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2511937619","title":"Lisata Therapeutics, Inc.盘中异动 急速跳水6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511937619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511937619?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:13","pubTimestamp":1739560412,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时13分，Lisata Therapeutics, Inc.股票出现异动，股价快速跳水6.49%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503133296235a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503133296235a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","LENZ","BK4139"],"gpt_icon":0},{"id":"2510331311","title":"Lisata Therapeutics, Inc.盘中异动 早盘急速下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510331311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510331311?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:09","pubTimestamp":1739290160,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时09分，Lisata Therapeutics, Inc.股票出现波动，股价急速下挫5.36%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2770.35%、1222.02%、406.97%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000920abcb1bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000920abcb1bdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lisata.com","stockEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":0.1435},{"period":"3month","weight":1.5482},{"period":"6month","weight":1.0324},{"period":"1year","weight":1.0826},{"period":"ytd","weight":1.6989}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lisata Therapeutics, Inc.根据美国特拉华州法律在富达医疗服务有限公司的名义下于1980年9月注册成立，并于2006年1月在当前市场开始运营。该公司是一家临床阶段的制药公司，致力于发现、开发和商业化治疗实体瘤和其他重大疾病的创新疗法。该公司的主要研究候选产品LSTA1（原名CEND-1）旨在激活一种新的摄取途径，使联合给药或捆绑的抗癌药物能够更有效地穿透实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.263077},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.034282},{"month":3,"riseRate":0.727273,"avgChangeRate":0.051254},{"month":4,"riseRate":0.3,"avgChangeRate":-0.098618},{"month":5,"riseRate":0.3,"avgChangeRate":-0.006081},{"month":6,"riseRate":0.6,"avgChangeRate":0.073889},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.054717},{"month":8,"riseRate":0.090909,"avgChangeRate":-0.092076},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.004567},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.121215},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.024316},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.083616}],"exchange":"NASDAQ","name":"LISATA THERAPEUTICS INC","nameEN":"LISATA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LISATA THERAPEUTICS INC(LSTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LISATA THERAPEUTICS INC,LSTA,LISATA THERAPEUTICS INC股票,LISATA THERAPEUTICS INC股票老虎,LISATA THERAPEUTICS INC股票老虎国际,LISATA THERAPEUTICS INC行情,LISATA THERAPEUTICS INC股票行情,LISATA THERAPEUTICS INC股价,LISATA THERAPEUTICS INC股市,LISATA THERAPEUTICS INC股票价格,LISATA THERAPEUTICS INC股票交易,LISATA THERAPEUTICS INC股票购买,LISATA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LISATA THERAPEUTICS INC(LSTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}